SEARCH

SEARCH BY CITATION

References

  • 1
    Correa P. Human gastric carcinogenesis: a multistep and multifactorial process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 673540.
  • 2
    Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995; 19(Suppl. 1): S3743.
  • 3
    Rugge M, Cassaro M, Leandro G, et al. Helicobacter pylori in promotion of gastric carcinogenesis. Dig Dis Sci 1996; 41: 9505.
  • 4
    Correa P. Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol 1988; 83: 5049.
  • 5
    Yardley JH. Pathology of chronic gastritis and duodenitis. Monogr Pathol 1990; 31 : 69143.
  • 6
    Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 116181.
  • 7
    Solcia E, Fiocca R, Luinetti O, et al. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol 1996; 20(Suppl. 1): S822.
  • 8
    Filipe MI, Munoz N, Matko I, et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994; 57: 3249.
  • 9
    Watanabe H. The pathological sequence in the development of gastric cancer: II. Scand J Gastroenterol Suppl 1996; 214: 369.
  • 10
    Cassaro M, Rugge M, Gutierrez O, Leandro G, Graham DY, Genta RM. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol 2000; 95: 14318.
    Direct Link:
  • 11
    Genta RM. Recognizing atrophy: another step toward a classification of gastritis. Am J Surg Pathol 1996; 20(Suppl. 1): S2330.
  • 12
    Genta RM. Review article: gastric atrophy and atrophic gastritis—nebulous concepts in search of a definition. Aliment Pharmacol Ther 1998; 12(Suppl. 1): 1723.
  • 13
    Andrew A, Wyatt JI, Dixon MF. Observer variation in the assessment of chronic gastritis according to the Sydney system. Histopathology 1994; 25: 31722.
  • 14
    El-Zimaity HM, Graham DY, Al-Assi MT, et al. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol 1996; 27: 3541.
  • 15
    Chen XY, Van Der Hulst RW, Bruno MJ, et al. Interobserver variation in the histopathological scoring of Helicobacter pylori related gastritis. J Clin Pathol 1999; 52: 6125.
  • 16
    Offerhaus GJ, Price AB, Haot J, et al. Observer agreementonthe grading of gastric atrophy. Histopathology 1999; 34: 3205.DOI: 10.1046/j.1365-2559.1999.00635.x
  • 17
    Schoenfeld P, Guyatt G, Hamilton F, et al. An evidence-based approach to gastroenterology diagnosis. Gastroenterology 1999; 116: 12307.
  • 18
    Genta RM, Rugge M. Gastric precancerous lesions: headingforan international consensus. Gut 1999; 45(Suppl. 1): I58.
  • 19
    Rugge M, Correa P, Dixon MF, et al. Gastric dysplasia: the Padova international classification. Am J Surg Pathol 2000; 24: 16776.
  • 20
    Genta RM. Helicobacter pylori, inflammation, mucosal damage, and apoptosis: pathogenesis and definition of gastric atrophy. Gastroenterology 1997; 113(6 Suppl.): S5155.
  • 21
    Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 1991; 6: 20922.
  • 22
    Genta RM, Lew GM, Graham DY. Changes in the gastric mucosa following eradication of Helicobacter pylori. Mod Pathol 1993; 6: 2819.
  • 23
    Cassaro M, Di Mario F, Leandro G, Genta RM, Rugge M. The dark side of the gastric biopsy. Hum Pathol 1999; 30: 7414.
  • 24
    Owen DA. Normal histology of the stomach. Am J Surg Pathol 1986; 10: 4861.
  • 25
    Satoh K, Kimura K, Taniguchi Y, et al. Biopsy sites suitable for the diagnosis of Helicobacter pylori infection and the assessment of the extent of atrophic gastritis. Am J Gastroenterol 1998; 93: 56973.
    Direct Link:
  • 26
    Van Zanten SJ, Dixon MF, Lee A. The gastric transitional zones: neglected links between gastroduodenal pathology and Helicobacter ecology. Gastroenterology 1999; 116: 121729.
  • 27
    Sipponen P, Stolte M. Clinical impact of routine biopsies of the gastric antrum and body. Endoscopy 1997; 29: 6718.
  • 28
    Correa P, Haenszel W, Cuello C, et al. Gastric precancerous process in a high risk population: cross-sectional studies. Cancer Res 1990; 50: 47316.
  • 29
    Correa P, Haenszel W, Cuello C, et al. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res 1990; 50: 473740.
  • 30
    Hattori T. Development of adenocarcinomas in the stomach. Cancer 1986; 57: 152834.
  • 31
    Wright NA. Migration of the ductular elements of gut-associated glands gives clues to the histogenesis of structures associated with responses to acid hypersecretory state: the origins of ‘gastric metaplasia’ in the duodenum of the specialized mucosa of Barrett's esophagus and of pseudopyloric metaplasia. Yale J Biol Med 1996; 69: 14753.
  • 32
    Solcia E, Fiocca R, Villani L, et al. Morphology and pathogenesis of endocrine hyperplasia, precarcinoid lesions, and carcinoids arising in chronic atrophic gastritis. Scand JGastroenterol 1991; 26(Suppl. 180): 14659.
  • 33
    Strickland RG, Mackay IR. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis 1973; 18: 42640.
  • 34
    Lechago J. Gastrointestinal neuroendocrine cell proliferations. Hum Pathol 1994; 25: 111422.
  • 35
    Dixon MF. Autoimmune reactions in type A and H. pylori gastritis. Helicobacter 1998; 3: 222.
  • 36
    Kimura K. Chronological transition of the fundic–pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 1972; 63: 58492.
  • 37
    Correa P, Fontham ET, Bravo JC, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 2000; 6(92): 18818.
  • 38
    Ruiz B, Garay J, Johnson W, et al. Morphometric assessment of gastric antral atrophy: comparison with visual evaluation. Histopathology 2001; 39(3): 23542.
  • 39
    Fleiss JL. Statistical Methods for Rates and Proportions, 2nd edn. New York: Wiley, 1981: 21236.
  • 40
    Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 15974.
  • 41
    Cicchetti DV, Feinstein AR. High agreement but low kappa: II.Resolving the paradoxes. J Clin Epidemiol 1990; 43: 5518.
  • 42
    Feinstein AR, Cicchetti DV. High agreement but low kappa: I. The problems of two paradoxes. J Clin Epidemiol 1990; 43: 5439.
  • 43
    Morris JA. Information and observer disagreement in histopathology. Histopathology 1994; 25: 1238.
  • 44
    Genta RM. ‘We used the Sydney System…’. Am J Gastroenterol 1997; 92: 19601.
  • 45
    Lewin DN, Lewin KJ, Weinstein WM. Pathologist–gastroenterologist interaction. The changing role of the pathologist. Am J Clin Pathol 1995; 103(4 Suppl. 1): S912.
  • 46
    Scottish Intercollegiate Guidelines Network. http://www.sign.ac.uk/methodology/index.html .